St Francis Medical Center
13710 St. Francis Boulevard, Midlothian, VA · Bonsecours · · NPI 1447212592
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Culture screening strep group a CPT 87081 | $136.20 | $227.00 | not published | 0 |
| Culture typing immunologic CPT 87147 | $73.20 | $122.00 | not published | 0 |
| Culture typing nucleic acid probe amplified per culture/isolate 6 or more targets CPT 87154 | $832.80 | $1,388.00 | not published | 0 |
| Culture typing nucleic acid probe amplified per culture/isolate each organism CPT 87150 | $135.00 | $225.00 | not published | 0 |
| Culture urine each isolate CPT 87088 | $94.80 | $158.00 | not published | 0 |
| Cutter lead HCPCS C1773 | $18,560.43 | $30,934.05 | not published | 0 |
| Cyanocobalamin (vit b-12) 1,000 mcg/ml injection solution HCPCS J3420 | $48.00 | $80.00 | not published | 0 |
| Cyclic citrullinated peptide antibody CPT 86200 | $121.20 | $202.00 | not published | 0 |
| Cyclophosphamide 1 gram intravenous powder for solution HCPCS J9075 | $1,027.75 | $1,712.91 | not published | 0 |
| Cyclophosphamide 25 mg capsule HCPCS J8530 | $67.40 | $112.34 | not published | 0 |
| Cyclosporine 2 hour CPT 80158 | $226.80 | $378.00 | not published | 0 |
| Cyclosporine modified 25 mg capsule HCPCS J7515 | $43.11 | $71.85 | not published | 0 |
| Cyclosporine oral 100 mg HCPCS J7502 | $148.91 | $248.19 | not published | 0 |
| Cygnus, per sq cm HCPCS Q4170 | $23,395.50 | $38,992.50 | not published | 0 |
| Cylinder pump set 20cm titan zero angl HCPCS C1813 | $75,754.89 | $126,258.15 | not published | 0 |
| Cyp2c9 gene com variants CPT 81227 | $550.80 | $918.00 | not published | 0 |
| Cyp3a4 gene common variants CPT 81230 | $524.40 | $874.00 | not published | 0 |
| Cyp3a5 gene common variants CPT 81231 | $524.40 | $874.00 | not published | 0 |
| Cystatin c CPT 82610 | $130.80 | $218.00 | not published | 0 |
| Cystine urine quantitative CPT 82131 | $74.40 | $124.00 | not published | 0 |
| Cystogram >= 3 views supervision & interpretation CPT 74430 | $839.40 | $1,399.00 | not published | 0 |
| Cysto impl 4 or more HCPCS C9740 | $35,400.73 | $59,001.22 | $9,236.28 – $9,236.28 | 3 |
| Cysto, litho, vacuum kidney HCPCS C9761 | $39,912.74 | $66,521.23 | $9,236.28 – $9,236.28 | 3 |
| Cysto rx balo cath urtl strx CPT 52284 | $27,275.55 | $45,459.25 | $5,231.42 – $5,231.42 | 2 |
| Cystoscopy and treatment CPT 52234 | $15,574.50 | $25,957.50 | $3,439.27 – $3,439.27 | 3 |
| Cystoscopy and treatment CPT 52235 | $11,892.81 | $19,821.35 | $3,439.27 – $3,439.27 | 3 |
| Cystoscopy and treatment CPT 52240 | $19,865.86 | $33,109.77 | $5,231.42 – $5,231.42 | 3 |
| Cystoscopy and treatment CPT 52310 | $7,674.94 | $12,791.57 | $2,039.56 – $2,039.56 | 3 |
| Cystoscopy and treatment CPT 52315 | $1,546.20 | $2,577.00 | not published | 0 |
| Cystoscopy (Bladder Scope) CPT 52000 | $7,444.28 | $12,407.13 | $680.34 – $680.34 | 3 |
| Cystoscopy & ureter catheter CPT 52005 | $19,023.41 | $31,705.68 | $2,039.56 – $2,039.56 | 3 |
| Cystouretero & or pyeloscope CPT 52351 | $14,519.98 | $24,199.97 | $3,439.27 – $3,439.27 | 3 |
| Cystouretero w/biopsy CPT 52354 | $39,912.74 | $66,521.23 | $9,236.28 – $9,236.28 | 3 |
| Cysto/uretero w/lithotripsy CPT 52356 | $23,274.23 | $38,790.38 | $5,231.42 – $5,231.42 | 3 |
| Cystouretero w/lithotripsy CPT 52353 | $16,651.03 | $27,751.72 | $5,231.42 – $5,231.42 | 3 |
| Cystourethroscop/calib/dilat stric 52281 CPT 52281 | $11,040.84 | $18,401.40 | $2,039.56 – $2,080.35 | 3 |
| Cystourethroscopy w/biopsy(s) 52204 CPT 52204 | $14,605.66 | $24,342.77 | $2,039.56 – $2,039.56 | 3 |
| Cytogenomic neo microra alys CPT 81277 | $1,837.80 | $3,063.00 | not published | 0 |
| Cytomegalovirus (cmv) antibody igg CPT 86644 | $158.40 | $264.00 | not published | 0 |
| Cytomegalovirus (cmv) antibody igm CPT 86645 | $162.00 | $270.00 | not published | 0 |
| Cytopathology cellular enhancement technique non-gyn CPT 88112 | $544.20 | $907.00 | not published | 0 |
| Cytopathology cervical/vaginal thin layer manual screening CPT 88142 | $67.80 | $113.00 | not published | 0 |
| Cytopathology concentration technique smears & interpretation CPT 88108 | $152.40 | $254.00 | not published | 0 |
| Cytopathology fluids/washings/brushings smears with interpretation CPT 88104 | $80.40 | $134.00 | not published | 0 |
| Cytopathology fna adequacy evaluation each separate additional episode same site CPT 88177 | $105.60 | $176.00 | not published | 0 |
| Cytopathology fna adequacy evaluation first episode each site CPT 88172 | $187.80 | $313.00 | not published | 0 |
| Cytopathology fna adequacy evaluation first episode each site interp/rpt CPT 88173 | $423.00 | $705.00 | not published | 0 |
| Cytopath smear other source CPT 88160 | $93.60 | $156.00 | not published | 0 |
| Cytopath smear oth prep screen & interp CPT 88161 | $113.40 | $189.00 | not published | 0 |
| Dalbavancin 500 mg intravenous solution HCPCS J0875 | $9,714.05 | $16,190.09 | not published | 0 |
| Daptomycin 500 mg/10 ml intravenous solution HCPCS J0878 | $163.80 | $273.00 | not published | 0 |
| Darbepoetin alfa 100 mcg/0.5 ml in polysorbate injection syringe HCPCS J0881 | $21,130.20 | $35,217.00 | not published | 0 |
| D&c/diagnostic/therapeutic/non ob 58120 CPT 58120 | $7,428.17 | $12,380.28 | $3,158.41 – $3,158.41 | 3 |
| Dch validity tests CPT 81002 | $51.00 | $85.00 | not published | 0 |
| Deamidated gliadin antibody iga CPT 86258 | $40.20 | $67.00 | not published | 0 |
| Debrid ecz/inf skin up tp 10% body 11000 CPT 11000 | $1,210.80 | $2,018.00 | not published | 0 |
| Debridement (>20 cm) charge pt CPT 97598 | $307.80 | $513.00 | not published | 0 |
| Debridement bone <= 20 sq cm CPT 11044 | $4,845.60 | $8,076.00 | $1,611.44 – $1,611.44 | 3 |
| Debridement/bone/20 sq cm or less 11046 CPT 11046 | $481.80 | $803.00 | not published | 0 |
| Debridement/bone/ea add 20 sq cm 11047 CPT 11047 | $1,496.40 | $2,494.00 | not published | 0 |
| Debridement subcutaneous tissue <= 20 sq cm CPT 11042 | $8,962.20 | $14,937.00 | $396.63 – $396.63 | 3 |
| Debride nail6 or more 11721 CPT 11721 | $229.80 | $383.00 | not published | 0 |
| Debride skin bone at fx site CPT 11012 | $11,593.06 | $19,321.77 | $2,834.09 – $3,192.44 | 3 |
| Debride/subq tissue/ea add 20sq cm 11045 CPT 11045 | $3,163.80 | $5,273.00 | $396.63 – $396.63 | 3 |
| Debr musc/fascia 20sq cm/< 11043 CPT 11043 | $4,436.40 | $7,394.00 | $721.10 – $721.10 | 3 |
| Decalcification CPT 88311 | $79.20 | $132.00 | not published | 0 |
| Decitabine 50 mg intravenous solution HCPCS J0894 | $264.30 | $440.50 | not published | 0 |
| Declotting thrombolytic agent implanted vas access device 36 CPT 36593 | $606.00 | $1,010.00 | not published | 0 |
| Deferoxamine 500 mg solution for injection HCPCS J0895 | $432.60 | $721.00 | not published | 0 |
| Degarelix 120 mg subcutaneous solution HCPCS J9155 | $4,343.92 | $7,239.86 | not published | 0 |
| Delayed breast prosthesis 19342 CPT 19342 | $69,032.87 | $115,054.78 | $7,974.65 – $7,974.65 | 3 |
| Demonstration/evaluation utilization aersol generator/nebulizer/metered dose inhaler/ippb device CPT 94664 | $185.40 | $309.00 | not published | 0 |
| Denosumab 120 mg/1.7 ml (70 mg/ml) subcutaneous solution HCPCS J0897 | $18,835.58 | $31,392.64 | not published | 0 |
| Dentoalveolar/drain abs/cyst/hema 41800 CPT 41800 | $97.20 | $162.00 | not published | 0 |
| Dermapure 1 square cm HCPCS Q4152 | $10,372.01 | $17,286.68 | not published | 0 |
| Desmopressin 4 mcg/ml injection solution HCPCS J2597 | $103.69 | $172.82 | not published | 0 |
| Desoxycorticosterone CPT 82633 | $166.20 | $277.00 | not published | 0 |
| Dest mal lesion tal <0.5 17260 CPT 17260 | $378.60 | $631.00 | not published | 0 |
| Destroy cervthor facet jnt 64633 CPT 64633 | $3,745.80 | $6,243.00 | not published | 0 |
| Destroy cth facet jnt addl 64634 CPT 64634 | $3,745.80 | $6,243.00 | not published | 0 |
| Destruction anal lesion(s) CPT 46924 | $10,990.89 | $18,318.15 | $2,708.17 – $2,708.17 | 3 |
| Destruction benign lesions < 14 lesions CPT 17110 | $9,613.31 | $16,022.18 | $129.90 – $129.90 | 3 |
| Destruction by neurolytic agent w/imaging guidance lumbar/sacral additional (both sides) CPT 64636 | $3,745.80 | $6,243.00 | not published | 0 |
| Destruction by neurolytic agent w/imaging guidance lumbar/sacral (both sides) CPT 64635 | $3,745.80 | $6,243.00 | not published | 0 |
| Developmental screen/score/document 96110 CPT 96110 | $17.40 | $29.00 | not published | 0 |
| Device ablt adv novasure HCPCS C1886 | $25,215.15 | $42,025.25 | not published | 0 |
| Device hemospray 7frx220cm endo hemostat min access HCPCS C1052 | $12,997.50 | $21,662.50 | not published | 0 |
| Device intraute mirena HCPCS J7298 | $1,241.40 | $2,069.00 | not published | 0 |
| Device sut capio slim opn HCPCS C2631 | $5,947.66 | $9,912.76 | not published | 0 |
| Device tiss remov myosure reach HCPCS C1782 | $4,815.58 | $8,025.96 | not published | 0 |
| Dexa bone density study >=1 sites appendicular skeleton (peripheral) CPT 77081 | $147.60 | $246.00 | not published | 0 |
| Dexamethasone 4 mg tablet HCPCS J8540 | $9.54 | $15.90 | not published | 0 |
| Dexamethasone in ns IV syringe 0.1 mg/ml (neonate) - cnr HCPCS J1100 | $48.00 | $80.00 | not published | 0 |
| Dextran 40 infusion HCPCS J7100 | $698.25 | $1,163.75 | not published | 0 |
| Dextrose 5 % and 0.9 % sodium chloride intravenous solution HCPCS J7042 | $201.60 | $336.00 | not published | 0 |
| Dextrose 5 % in water (d5w) intravenous solution (non-pvc) HCPCS J7060 | $193.20 | $322.00 | not published | 0 |
| Dextrose 5 % IV bolus HCPCS J7070 | $201.60 | $336.00 | not published | 0 |
| Dhea-s (dehydroepiand sulfate) CPT 82627 | $167.40 | $279.00 | not published | 0 |
| Diabetes (HbA1c) Test CPT 83036 | $117.00 | $195.00 | not published | 0 |
| Diag laparo separate proc 49320 CPT 49320 | $17,829.51 | $29,715.85 | $5,898.53 – $5,898.53 | 3 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.